Maria C. Piccirillo
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial.
Journal: Future oncology (London, England)
Published: August 27, 2026
Request and reporting models for computed tomography in the multidisciplinary management of cancer patients: consensus between the Italian Society of Medical and Interventional Radiology (SIRM) and the Italian Society of Medical Oncology (AIOM).
Journal: La Radiologia medica
Published: December 22, 2025
Effect of co-occurring mutations in TP53 gene and TERT promoter on the survival of bladder cancer patients.
Journal: Frontiers in immunology
Published: December 19, 2025
Patient Journey for Triple-Negative Breast Cancer: Optimal Care Pathways vs. Reality of Care in Italian Breast Units.
Journal: Current oncology (Toronto, Ont.)
Published: December 19, 2025
Validity and responsiveness of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) among Italian lung cancer patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 17, 2025
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients.
Journal: Journal of cancer policy
Published: May 22, 2025
A Post Hoc Analysis of Older Patients with Metastatic Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy Plus Bevacizumab: The Randomized Obelics Study.
Journal: Drugs & aging
Published: February 17, 2025
Comparison of baseline patient characteristics in phase 1 and phase 2/3 clinical trials for anticancer treatments.
Journal: Journal of translational medicine
Published: February 11, 2025
Corrigendum to "Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials": [ESMO Open 9 (2024) 102941].
Journal: ESMO open
Published: December 01, 2024
Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819]".
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 08, 2024
Last Updated: 09/26/2026